A recent Northwestern Medicine perspective piece published in journal Academic Medicine discussed how the COVID-19 pandemic could impact gender equity within the field, specifically the retention and advancement of women.
Browsing: Melissa Rohman
Tanya Simuni, MD, director of the Parkinson’s Disease and Movement Disorders Center, has received a multimillion-dollar grant from The Michael J. Fox Foundation to identify biomarkers of Parkinson’s disease progression for use in clinical trials for novel therapies.
Kristine Healy, MPH, PA-C, assistant professor of Medical Education and associate director of Feinberg’s Physician Assistant program, has received the Illinois Academy of Physician Assistants’ Lifetime Achievement Award for her service and dedication to physician assistant advocacy, education and clinical practice.
Targeting the proteins CD47 and HER2 may eliminate radioresistant breast cancer cells and enable more effective radiotherapy treatments for patients, according to a new study.
Nicholas Soulakis, PhD, assistant professor of Preventive Medicine in the Divisions of Health and Biomedical Informatics and Epidemiology, discussed lessons learned from his experience leading COVID-19 contract tracing efforts for the Illinois Department of Public Health during a recent webinar.
The impact of COVID-19 on cancer patients has been a stark reality for many cancer centers around the world. For the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, a combination of time and dedication to patient care and research has resulted in the development of robust COVID-19 testing protocols to ensure the safety and health of every patient, physician and staff member.
A rare genetic mutation found in patients with Alzheimer’s may provide further insight into the pathologic mechanisms that cause the disease.
A new study found that Black men with metastatic prostate cancer were more likely to have tumor mutations than white or Asian men, highlighting the significance genetic drivers have in increasing one’s risk for developing aggressive prostate cancer.
In collaboration with the Office of Diversity and Inclusion, student groups organized the medical school’s first Diversity and Inclusion Week, which explored the importance of diversity, inclusion and representation in medicine and society.
A first of its kind drug called vosoritide may increase bone growth in children with achondroplasia, the most common form of dwarfism, according to findings from a recent clinical trial.